Endoscopic versus open surgery in patients with malignant sinonasal tumors and brain invasion. A case series study

xlomafota13 shared this article with you from Inoreader Endoscopic versus open surgery in patients with malignant sinonasal tumors and brain invasion. A case series study Via Sociedad Luso-Española de Neurocirugía Neurocirugia (Astur). 2021 Jun 23:S1130-1473(21)00051-8. doi: 10.1016/j.neucir.2021.04.002. Online ahead of print. ABSTRACT OBJECTIVES: To determine the safety, effectiveness and perioperative costs of endonasal endoscopic approach in brain invasive malignant sinonsal tumors patients. MATERIALS AND METHODS: This was a case series bidirectional study; that included 30 brain invasive malignant sinonsal tumors patients treated by endonasal endoscopic approach (2015-2017) and 53 by open surgery (2010-2015). Propensity score matching was used to compensate the prognostic factors; in a sample of 50 patients (25 per group). Primary response variables was local control and 3-years overall survival. Perioperative cost variables were analyzed. RESULTS: A number of 50 patients were included after matching (25 in each therapeutic group). The age average was 55 years and male proportion was 62%. Squamous cell carcinoma and grade II lesions wer e the most represented in the sample. Endonasal endoscopic approach reduced surgical time in 1 hour 20 minutes, transfusion needs in 5.5 fold and hospitalization in 19 days; in comparison with open technique. Oncologic control based on surgical free margins, local control, overall survival and progression free survival after three years was higher when the resection was performed endoscopically. Functional status was enhanced and complications diminished by using endoscopic approach. Saving was estimated in $7 355.18 per patient. CONCLUSIONS: Endonasal endoscopic approach represents a safe, effective and economic procedure in selected patients with malignant sinonasal tumors and brain invasion. PMID:34175220 | DOI:10.1016/j.neucir.2021.04.002 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.